Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study
Titel:
Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study
Auteur:
Pivot, X. Gligorov, J. Müller, V. Curigliano, G. Knoop, A. Verma, S. Jenkins, V. Scotto, N. Osborne, S. Fallowfield, L.